Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic disease

R S Freedman1, G Tortolero-Luna, D K Pandey

  • 1Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.

Obstetrics and Gynecology Clinics of North America
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complementary gene interaction and xenia effect controls the seed coat colour in interspecific cross between Trifolium alexandrinum and T. apertum.

Genetica·2019
Same author

Identification of new deep sea sinuous channels in the eastern Arabian Sea.

SpringerPlus·2016
Same author

The molecular pathology of ovarian serous borderline tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Evaluation of antioxidant, antibacterial, and antidiabetic potential of two traditional medicinal plants of India: Swertia cordata and Swertia chirayita.

Pharmacognosy research·2015
Same author

Inhibitory effect of parthenium (Parthenium hysterophorus L.) residue on growth of water hyacinth (Eichhornia crassipes mart solms.) I. Effect of leaf residue.

Journal of chemical ecology·2013
Same author

Inhibitory effect of parthenium (Parthenium hysterophorus L.) residue on growth of water hyacinth (Eichhornia crassipes Mart Solms.) II. Relative effect of flower, leaf, stem, and root residue.

Journal of chemical ecology·2013
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Gestational Trophoblastic Disease (GTD) is rare in the US but common in Asia and Latin America. Early diagnosis and prompt treatment are crucial for better outcomes in GTD patients.

Area of Science:

  • Gynecology
  • Obstetrics
  • Oncology

Background:

  • Gestational Trophoblastic Disease (GTD) presents a rare but significant complication of pregnancy.
  • Incidence varies globally, with higher rates observed in Asia and Latin America compared to the United States.
  • Identified risk factors include advanced maternal age, young maternal age, low socioeconomic status, and a history of hydatidiform mole.

Purpose of the Study:

  • To emphasize the importance of recognizing GTD signs and symptoms for timely diagnosis and treatment.
  • To discuss the implications of GTD's low incidence on general population screening strategies.
  • To explore potential chemopreventive measures for women at high risk for GTD.

Main Methods:

  • Review of epidemiological data on GTD incidence across different regions.

Related Experiment Videos

  • Analysis of established risk factors associated with GTD development.
  • Evaluation of diagnostic and treatment paradigms for GTD.
  • Consideration of screening and chemoprevention strategies.

    • Main Results:

    • GTD occurs in fewer than 1 in 1200 pregnancies in the US, but as high as 1 in 200 in parts of Asia and Latin America.
    • Early diagnosis and prompt treatment are critical for favorable patient outcomes.
    • General population screening for GTD is deemed not worthwhile due to low incidence and occurrence post-reproductive events.

    Conclusions:

    • Physician awareness of GTD signs and symptoms is vital for prompt diagnosis and management.
    • Targeted screening and chemoprevention strategies may be more appropriate than general population screening.
    • Oral contraceptives are proposed as a potential candidate for chemoprevention in at-risk populations, warranting further study.